Table 2.
Parameters of thrombin generation in PRP from patients with mild and moderate hemophilia B
Patients with mild hemophilia B (n = 5) | Patients with moderate hemophilia B (n = 3) | |||||
---|---|---|---|---|---|---|
PRP alone | PRP + irrelevant IgG | PRP + anti-PN-1 | PRP alone | PRP + irrelevant IgG | PRP + anti-PN-1 | |
Lag time, min | 11.53 ± 1.55 | 11.33 ± 1.76 | 11.41 ± 1.87 | 14.62 ± 2.09 | 15.29 ± 3.57 | 15.74 ± 3.90 |
Peak, nM | 75.28 ± 11.50 | 77.49 ± 12.65 | 97.73 ± 16.28* | 29.92 ± 6.12 | 31.07 ± 5.41 | 43.09 ± 3.31 |
TTP, min | 22.31 ± 3.76 | 21.88 ± 3.91 | 20.69 ± 2.78 | 27.11 ± 2.93 | 30.01 ± 6.32 | 29.73 ± 3.53 |
ETP, nM⋅min | 1368 ± 411.2 | 1395 ± 374.4 | 1292 ± 303.4 | 775,6 ± 173.0 | 1013 ± 491.1 | 813.1 ± 264.9 |
Velocity, nM/min | 7.44 ± 1.92 | 7.51 ± 1.98 | 10.60 ± 1.73* | 2,47 ± 0.80 | 2.33 ± 0.85 | 2.80 ± 0.44 |
Means ± SD. A nonparametric 1-way ANOVA test followed by a multiple comparison test was used.
P < .05 vs PRP + irrelevant IgG.